EUVIMEDEUVIMED entdecken
Crossref

Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide‐induced immunosuppression and intestinal microbiota disorder in mice

Mingming Zhu, Lvzhu Yang iD, Sufen Kong, Yuyuan Bai, Bin Zhao

Journal of Food Science · 2024

DOI: 10.1111/1750-3841.17538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food Science, 2024. Verfasst von Mingming Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wuhan Wecare Probiotic Research Institute, Wuhan, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lacticaseibacillus rhamnosus, Cyclophosphamide, Probiotics. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Wecare-HZAU Cooperation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Probiotics play a crucial role in regulating the gut microbiota and enhancing immune response. Oral administration of probiotics modulates intestinal microbiota composition and immune homeostasis. In this study, we investigated the immunoregulatory effect of Lacticaseibacillus rhamnosus LRa05 on cyclophosphamide (CTX)‐induced immunosuppressive mice. The results showed that oral administration of LRa05 reduced weight loss, restored immune organ indices, and maintained the structural integrity of the intestinal tissue in CTX‐treated mice. Moreover, oral administration of LRa05 exhibited immune‐modulating properties by promoting the secretion of cytokines (tumor necrosis factor‐α, interleukin‐1β, interleukin‐10, and secretory immunoglobulin A) in serum. Moreover, the analysis of 16S rRNA amplicon sequencing revealed that LRa05 increased gut microbiota diversity and regulated its composition. In detail, LRa05 intervention restored the Firmicutes/Bacteroidota ratio and significantly increased the relative abundance of Lachnospiraceae_NK4A136_group , Oscillibacter , Alloprevotella , Parasutterella , and Roseburia in immunocompromised mice. Conversely, the abundances of Helicobacter , Bacteroides , and unclassified_Desulfovibrionaceae were significantly decreased after administration of LRa05. Based on these findings, orally administered LRa05 could effectively maintain intestinal microbiota homeostasis and regulate immunity, suggesting the potential of L. rhamnosus LRa05 as a candidate probiotic strain in the application of dietary supplement. Practical Application Supplement with L. rhamnosus LRa05 can improve immunity, regulate gut microbiota and promote body health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLacticaseibacillus rhamnosusCyclophosphamideProbioticsAnimalsMiceMaleCytokinesRNA, Ribosomal, 16S

Stichwörter der Autor:innen

Lacticaseibacillus rhamnosus LRa05cyclophosphamidecytokinesgut microbiotaimmunosuppressive mice

Substanzen

CyclophosphamideCytokinesRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Wuhan Wecare Probiotic Research Institute, Wuhan, China.
  • National Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, China.

ORCID-Profile: Lvzhu Yang

Förderung

  • Wecare-HZAU Cooperation program

Zitieren

APA

Zhu, M., Yang, L., Kong, S., Bai, Y., & Zhao, B. (2024). Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide‐induced immunosuppression and intestinal microbiota disorder in mice. Journal of Food Science. https://doi.org/10.1111/1750-3841.17538

Vancouver

Zhu M, Yang L, Kong S, Bai Y, Zhao B. Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide‐induced immunosuppression and intestinal microbiota disorder in mice. Journal of Food Science. 2024. doi:10.1111/1750-3841.17538

BibTeX
@article{Zhu2024,
  author = {Zhu, Mingming and Yang, Lvzhu and Kong, Sufen and Bai, Yuyuan and Zhao, Bin},
  title = {Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide‐induced immunosuppression and intestinal microbiota disorder in mice},
  journal = {Journal of Food Science},
  year = {2024},
  doi = {10.1111/1750-3841.17538}
}
Kostenlos starten →